Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease.

Neurology
S HoopsDaniel Weintraub

Abstract

Due to the high prevalence of mild cognitive impairment (MCI) and dementia in Parkinson disease (PD), routine cognitive screening is important for the optimal management of patients with PD. The Montreal Cognitive Assessment (MoCA) is more sensitive than the commonly used Mini-Mental State Examination (MMSE) in detecting MCI and dementia in patients without PD, but its validity in PD has not been established. A representative sample of 132 patients with PD at 2 movement disorders centers was administered the MoCA, MMSE, and a neuropsychological battery with operationalized criteria for deficits. MCI and PD dementia (PDD) criteria were applied by an investigator blinded to the MoCA and MMSE results. The discriminant validity of the MoCA and MMSE as screening and diagnostic instruments was ascertained. Approximately one third of the sample met diagnostic criteria for a cognitive disorder (12.9% PDD and 17.4% MCI). Mean (SD) MoCA and MMSE scores were 25.0 (3.8) and 28.1 (2.0). The overall discriminant validity for detection of any cognitive disorder was similar for the MoCA and the MMSE (receiver operating characteristic area under the curve [95% confidence interval]): MoCA (0.79 [0.72, 0.87]) and MMSE (0.76 [0.67, 0.85]), but as ...Continue Reading

Citations

Jan 5, 2011·Journal of Neurology·Han-Joon KimJoong-Yang Cho
Dec 1, 2012·Journal of Neural Transmission·C AnnweilerUNKNOWN WALK Team-Working group Angers-London for Knowledge
Apr 30, 2010·Current Neurology and Neuroscience Reports·Mary J Docherty, David J Burn
Apr 14, 2011·Current Neurology and Neuroscience Reports·Dag AarslandTormod Fladby
Jan 13, 2011·International Psychogeriatrics·Daniela C GonçalvesGerard J Byrne
May 6, 2010·Journal of the International Neuropsychological Society : JINS·Joseph BarrashMatthew Rizzo
Nov 17, 2011·The Clinical Neuropsychologist·David J LibonMurray Grossman
Dec 14, 2011·The Clinical Neuropsychologist·Kevin J ManningPaul J Moberg
Jun 7, 2011·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Robert PaulThomas E Conturo
Oct 7, 2011·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Gabor Abellan van KanBruno Vellas
Apr 9, 2011·Dementia and Geriatric Cognitive Disorders·Sylvia VilleneuveJean-François Gagnon
Mar 30, 2013·Translational Neurodegeneration·Rwei-Ling Yu, Ruey-Meei Wu
Nov 17, 2011·Clinical Interventions in Aging·Timothy C Y KwokFlorence K Y Ho
Jan 22, 2014·Canadian Journal on Aging = La Revue Canadienne Du Vieillissement·Alexandra Fortin, Nicole Caza
May 23, 2014·Brain Connectivity·Hongxiang YaoUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Jun 13, 2014·Translational Neurodegeneration·Justin B MillerJeffrey L Cummings
Mar 13, 2013·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Alberto CostaGiovanni Augusto Carlesimo
Apr 9, 2011·Journal of Genetic Counseling·Dana Clay FalconeVivianna M Van Deerlin
Sep 16, 2014·Annals of Indian Academy of Neurology·Srikanth Srinivasan
Apr 23, 2013·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Emmanuelle DagenaisPierre Duquette
Jan 5, 2011·Neuro-degenerative Diseases·Claudio L Bassetti
Mar 15, 2012·Dementia and Geriatric Cognitive Disorders·Ralf SaurThomas Leyhe
Jul 17, 2015·International Journal of Geriatric Psychiatry·Daniel S BrownLaura H Lacritz
Mar 6, 2016·Journal of the Neurological Sciences·Hanan KhalilJawad A Bajwa
May 19, 2012·Expert Review of Anticancer Therapy·Chip CaineVinai Gondi
Feb 20, 2016·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·K KonstantopoulosT Doskas
Mar 22, 2016·Movement Disorders Clinical Practice·Samantha K HoldenBenzi M Kluger
Mar 10, 2016·Journal of Clinical Movement Disorders·Clara WardenKathleen L Poston
Jan 23, 2016·Frontiers in Aging Neuroscience·Noelia CalvoAgustín Ibáñez
Apr 16, 2015·Traffic Injury Prevention·Dafne PiersmaWiebo Brouwer
May 31, 2016·Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring·Sally J VogelJustin B Miller
May 6, 2014·Journal of Clinical Lipidology·Carlos H Rojas-Fernandez The National Lipid Association's Safety Task Force

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.